New pricing deals and aggressive marketing are transforming expensive GLP-1 weight-loss drugs into mainstream treatments and creating the next mega-market for the pharmaceutical industry.
Why it matters: Americans have shown they're willing to pay thousands of dollars out of pocket for the treatments — making them more popular than ever even as insurers try to pump the brakes by restricting coverage.
